Literature DB >> 3893136

Penetrating keratoplasty combined with extracapsular cataract extraction.

S G Kramer.   

Abstract

In my previous prospective study of 132 eyes, the incidence of clinically significant cystoid macular edema was 42% in aphakic penetrating keratoplasty, 33% in combined keratoplasty and cataract extraction with vitrectomy, and only 4% in combined keratoplasty and cataract extraction without vitrectomy. In the present study we added 26 aphakic and 11 pseudophakic keratoplasties and 17 procedures combining keratoplasty with extracapsular cataract extraction. Grafts were clear in 94% of patients, and 43% had visual acuity of 20/40 or better. Clinically significant cystoid macular edema occurred in 35% of aphakic and 27% of pseudophakic keratoplasties. Cystoid macular edema did not occur in combined keratoplasty and extracapsular cataract extraction.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3893136     DOI: 10.1016/s0002-9394(14)74994-3

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  4 in total

1.  Efficacy of core vitrectomy preceding triple corneal procedure.

Authors:  K Konomi; J Shimazaki; S Shimmura; N Akabane; E Goto; K Tsubota
Journal:  Br J Ophthalmol       Date:  2004-08       Impact factor: 4.638

2.  Effects of posterior chamber lens implantation on the endothelium of transplanted corneas.

Authors:  N Ohguro; M Matsuda; S Kinoshita
Journal:  Br J Ophthalmol       Date:  1997-12       Impact factor: 4.638

3.  Triple procedure; analysis of outcome, refraction, and intraocular lens power calculation.

Authors:  A J Geerards; E Hassmann; W H Beekhuis; L Remeyer; G van Rij; W J Rijneveld
Journal:  Br J Ophthalmol       Date:  1997-09       Impact factor: 4.638

4.  Evaluation of an interlaced triple procedure: penetrating keratoplasty, extracapsular cataract extraction, and nonopen-sky intraocular lens implantation.

Authors:  Shuo Yang; Bin Wang; Yangyang Zhang; Hualei Zhai; Junyi Wang; Shuang Wang; Lixin Xie
Journal:  Medicine (Baltimore)       Date:  2017-09       Impact factor: 1.889

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.